French Officials Making Bold Move in Pharmaceutical Scandal

Somebody needs to be responsible for the deaths of innocent people!  We here in the United States call this justice, and it appears that in France, officials are trying to do just that in regards to the deaths of several hundred innocent people.

According to media reports, Magistrates in France are investigating and charging the head of the country’s second-largest drugmaker with involuntary manslaughter, aggravated deception, and fraud.

The head of the French pharmaceutical company Servier Laboratories, Jacques Servier, along with 5 other Servier units are reportedly facing a fraud investigation, including misleading the public about product quality and improperly obtaining authorization for the now-banned diabetes drug Mediator, which has been linked to the deaths of 500 people over the past three decades, Agence France-Presse reported in September.

I know if I was mislead into believing that a product was safe for me, and come to find out it wasn’t, I would want justice too!  How about you?!

Judges allege that Jacques Servier engaged in dishonest practices and deception over the drug’s quality and falsely obtained authorization to sell it, his lawyer, Herve Temime, told news outlets.

The investigation by the French national health-insurance organization, CNAM, concluded earlier this year that Mediator, (benfluorex) which was also used off-label as an appetite suppressant, likely caused 500 deaths and at least 3500 hospitalizations for valvular heart disease in France since coming on the market in 1979. Even higher numbers of possible deaths—upward of 2000—have been cited in the press; Servier, according to news reports, denies misleading patients and French authorities and has only recognized 38 deaths “linked to” the drug and just four as having been caused by it.

According to Bloomberg news, Servier’s chair must post bail of €4 million ($5.51 million), and his freedom may be restricted. Reuters notes that Servier must also guarantee possession of a further €6 million before December 15, and five additional companies affiliated with Servier must post €26 million ($36 million), with an additional guarantee of €39 million ($53 million).

The French drug-oversight agency, AFSSAPS (French Agency for Safety of Health Products), has previously issued a safety alert advising patients who took Mediator (benfluorex) for at least three months during the past four years of marketing (2006-2009).

And, the concern now is how many people may be affected by the misleading information, and dangerous product.  In hopes to spread a clear message of how important it is to be checked out, the French Health Minister, Xavier Bertrand, said in a news conference,  “Our message to all those who took Mediator is that they must see a doctor — particularly those who took it for three months over the past four years.”

Thankfully, the drug was removed from the market in France in 2009, well after other European countries; it was never approved in the US and other markets.

Can someone say it’s about time?!  My question is why in the world would it take 30 years to get a dangerous drug off the market?  That is absurd, and someone should definitely pay for it.



, , , ,

No comments yet.

Leave a Reply

GET HELP NOW!
  • This field is for validation purposes and should be left unchanged.
Latest Drug Injury News

Heightened Thrombosis Risk with Birth Control Patch and Ring

A BMJ study has found more evidence that women using the transdermal contraceptive patch or vaginal ring do indeed face higher thrombosis risks than those taking their contraceptive orally. Using Danish national registries, researchers studied over 1.5 million women without prior thrombotic disease or cancer, who were not pregnant. Overall, the incidence of venous thrombosis [...]

Is Your Heartburn Medication Putting You At Risk?

According to a new study, your heartburn medication could be putting you at risk for a nasty stomach bug! The infection, Clostridium difficile infection, also called C. difficile or CDI, is a hard-to-cure infection that causes severe diarrhea that has recently been linked to proton pump inhibitors (PPIs), the most powerful class of antacid drugs. [...]

Cipralex and Abnormal Heart Rhythms

Health Canada is informing Canadians of a labeling update for the prescription drug Cipralex (Escitalopram) regarding a dose-related risk of abnormal heart rhythms. The risk is dose-related, 20 mg per day is still the maximum recommended dose for most patients. Before starting Cipralex, talk to your healthcare professional. If you have had any heart problems, what other medications you [...]

Florida Compounding Pharmacy Linked To Rare Fungal Eye Infections

Whats that in my eye?! Thirty-three cases of a rare, but serious, fungal eye infection have been confirmed across seven states. Federal officials are announcing that the infection stemmed from products mixed in a Florida compounding pharmacy. it seems the victims underwent some sort of an eye procedure, either a surgery or injections. Of these, [...]

Multaq and Death By Heart Problems

Multaq, also known as Dronedarone, is used to treat heart patients that had atrial fibrillation, which is a rhythm disorder that could make the heart beat fast and irregular. It’s also used to treat atrial flutter, which also causes the heart to beat fast, but is still considered regular. However, this drug is known to [...]

Latest Medical Device Injury News

More Sufferers File Lawsuits Against DePuy Orthopaedics

Two more people who’ve suffered serious injuries blamed on the defective and recalled DePuy Orthopaedics ASR hip implant are the latest to join a growing federal class-action lawsuit against the medical device firm and its parent company, Johnson & Johnson. The plaintiff’s are being represented by the law firm of Parker Waichman LLP and are [...]

Metal-on-Metal Hip Implant Finds No Increased Cancer Risk?

We have written countless articles discussing the dangers of metal-on-metal implants, yet a new study is downplaying the potential dangerous effects, such as the risk of cancer. The recent study was published in the British Medical Journal which analyzed cancer rates among patients with metal-on-metal implants versus patients with other types of implants as well [...]

St. Jude’s Wants Study Retracted Due To Inaccuracy

St. Jude Medical has asked the Heart Rhythm Journal to retract a study published last month that linked its Riata line of internal defibrillator leads to more 20 deaths. In a statement issued by St. Jude, the company asserted the Riata lead study was biased and based on inaccurate facts. According to the Heart Rhythm [...]

Vaginal Mesh Lawsuits Claim Painful Erosion, Organ Damage

An estimated 35,000 women who suffered through bladder control problems brought on by aging, child birth, and a variety of other causes. The lives of those who had adverse reactions to vaginal mesh were literally ruined as many experienced crippling pain and permanent scarring damage from the procedures involved in the insertion and necessary removal of the vaginal mesh.

If you or a loved one suffered vaginal erosion call us immediately at 1-800-810-3457.

FDA Reposts Thoratec HeartMate II LVAS Class I Recall

A recall of Thoratec’s HeartMate II Left Ventricle Assist System (LVAS) that was first announced in February has been designated Class I, the U.S. Food & Drug Administration’s (FDA) most serious type of recall. The HeartMate II LVAS is a heart pump which is used as a bridge to transplantation in heart transplant candidates at [...]